As of Jul 22
| -0.16 / -3.35%|
The 4 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 15.13, with a high estimate of 24.00 and a low estimate of 8.00. The median estimate represents a +227.38% increase from the last price of 4.62.
The current consensus among 3 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.